Bio-Techne

TECHNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$11.318 B

$72.29 +0.54%

Close of 7 Aug 2026

Revenue

$1.22B

#1419 by revenue

Earnings

$73.4M

#1426 by earnings

Shares outstanding

156,568,751

Latest filing cover page

P/E ratio

154.2

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#9ExelixisEXEL$13.4B
#10Halozyme TherapeuticsHALO$12.2B
#11Bio-TechneTECH$11.3B
#12Apogee TherapeuticsAPGE$10.2B
#13Krystal BiotechKRYS$9.66B

Where these numbers come from

Share counts and financials for Bio-Techne are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.